T1	p 21 45	autism spectrum disorder
T2	p 308 340	autism spectrum disorder ( ASD )
T3	p 353 445	children and adolescents with both ASD and attention-deficit/hyperactivity disorder ( ADHD )
T4	p 467 516	97 patients 6-17 years of age , with ASD and ADHD
T5	i 6 17	Atomoxetine
T6	i 293 304	atomoxetine
T7	i 554 565	atomoxetine
T8	i 596 614	placebo-controlled
T9	i 855 866	atomoxetine
T10	i 1173 1184	atomoxetine
T11	o 62 80	social functioning
T12	o 110 154	stereotyped behaviors , inappropriate speech
T13	o 161 175	fear of change
T14	o 708 743	Aberrant Behavior Checklist ( ABC )
T15	o 752 802	Children 's Social Behavior Questionnaire ( CSBQ )
T16	o 939 1016	ABC subscales Hyperactivity , Inappropriate Speech , and Stereotypic Behavior
T17	o 1030 1060	CSBQ subscale Fear for Changes
T18	o 1215 1254	stereotyped behaviors and communication